GNRH1 and breast carcinoma: Ovarian suppression induced surgically or with a luteinizing-hormone-releasing hormone (LH-RH) analogue as a postoperative adjuvant therapy can prevent recurrence and prolong survival in premenopausal women with breast cancer.